HOME › News › World's first commercialization of hepatocyte-like cells derived from human iPS cells has been awarded!

News

World's first commercialization of hepatocyte-like cells derived from human iPS cells has been awarded!

2012.9.28

 A method, by which hepatocyte-like cells are efficiently differentiated from human iPS cells, has been developed at NIBIO. The induced hepatocyte-like cells have high drug metabolizing activities and are expected to be used for new drug screening. It is commercially available for the first time in the world, and has been awarded the 10th Industry-Academia-Government Collaboration Minister of Health, Labour and Welfare Prize!

back to list

page to top